Article Versions Notes

Cano-Garrido O, Álamo P, Sánchez-García L, Falgàs A, Sánchez-Chardi A, Serna N, Parladé E, Unzueta U, Roldán M, Voltà-Durán E, et al. Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4⁺ Cancers. Cancers. 2021; 13(12):2929. https://doi.org/10.3390/cancers13122929

Cano-Garrido, Olivia, Patricia Álamo, Laura Sánchez-García, Aïda Falgàs, Alejandro Sánchez-Chardi, Naroa Serna, Eloi Parladé, Ugutz Unzueta, Mònica Roldán, Eric Voltà-Durán, and et al. 2021. "Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4⁺ Cancers" Cancers 13, no. 12: 2929. https://doi.org/10.3390/cancers13122929

Cano-Garrido, O., Álamo, P., Sánchez-García, L., Falgàs, A., Sánchez-Chardi, A., Serna, N., Parladé, E., Unzueta, U., Roldán, M., Voltà-Durán, E., Casanova, I., Villaverde, A., Mangues, R., & Vázquez, E. (2021). Biparatopic Protein Nanoparticles for the Precision Therapy of CXCR4⁺ Cancers. Cancers, 13(12), 2929. https://doi.org/10.3390/cancers13122929